OneWorld Health

0 PATH & Sanofi start major production of synthetic anti-malaria drug

Malaria remains one of the world’s biggest killers and also a massive economic drag on poor countries, poor families. One of our best weapons against this scourge is a drug known as artemisinin, which is harvested from the plant sweet wormwood and, as a crop, is about as predictable as corn or hog futures.A major new initiative to be launched tomorrow in Italy by Seattle-based PATH in collaboration with the French drug maker Sanofi aims to do industrial production of synthetic artemisinin.

0 PATH acquires drug company to speed fight on neglected diseases

Seattle-based PATH announced today that it is acquiring the non-profit drug company OneWorld Health. OneWorld Health, which will continue to operate from its headquarters in San Francisco, was created in 2000 as the first non-profit pharmaceutical company and has been focused from the beginning on creating drugs and vaccines for…